Catheter-directed endovascular application of thrombin: Report of 3 cases and review of the literature Journal Article


Authors: Maybody, M.; Madoff, D. C.; Thornton, R. H.; Morales, S. A.; Moskowitz, C. S.; Hsu, M.; Brody, L. A.; Brown, K. T.; Covey, A. M.
Article Title: Catheter-directed endovascular application of thrombin: Report of 3 cases and review of the literature
Abstract: Purpose To report 3 new cases of catheter-directed endovascular application of thrombin and explore trends by analysis of published case series. Materials and methods Institutional Review Board approved this retrospective study. All cases of non-tumoral arterial embolization performed from January 2003 to January 2015 at our institution were retrospectively reviewed. Thrombin was used in 7 of 589 cases. In 3 cases intra arterial thrombin was injected via catheter to treat active hemorrhage. Four cases were excluded due to percutaneous injection into visceral pseudoaneurysms (n = 3) and making ex vivo autologous clot to be injected via catheter (n = 1). Fisher's exact and the Wilcoxon rank sum tests were used to assess for association with acute nontarget thrombosis. Results Catheter-directed thrombin was used in 3/589 (0.5%) cases at our institution. All three cases were technically successful with no further bleeding (100%). Nontarget thrombosis of proximal branches occurred in 2 patients (67%) with no significant clinical consequences. Including our 3 cases, a total of 28 cases were reviewed. Of the variables examined—location (p = 0.99), size (p = 0.66) and etiology of vascular lesion (p = 0.92), pseudoaneurysm neck anatomy (p = 0.14), thrombin units (p = 0.47), volume (p = 0.76) or technique of use of small doses (p = 0.99), use of other embolic material (p = 0.67) and use of adjunct techniques (p = 0.99)—none were found to be significantly associated with acute nontarget thrombosis. Technical success was 96% with no reports of reperfusion after treatment. Conclusions Catheter-directed endovascular thrombin can be an additional tool to treat pseudoaneurysms not amenable to conventional embolization. Further studies are required to optimize technique and outcomes. © 2016 Elsevier Inc.
Keywords: thrombosis; diseases; enzymes; blood vessels; thrombin; vascular lesions; wilcoxon rank sum test; arterial embolization; catheters; pseudoaneurysm; institutional review boards; endovascular; catheter-directed
Journal Title: Clinical Imaging
Volume: 42
ISSN: 0899-7071
Publisher: Elsevier Inc.  
Date Published: 2017-03-01
Start Page: 96
End Page: 105
Language: English
DOI: 10.1016/j.clinimag.2016.11.018
PROVIDER: scopus
PUBMED: 27936421
PMCID: PMC5499980
DOI/URL:
Notes: Article -- Export Date: 3 January 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Meier Hsu
    169 Hsu
  2. Anne Covey
    165 Covey
  3. Chaya S. Moskowitz
    278 Moskowitz
  4. Majid Maybody
    98 Maybody
  5. Lynn Brody
    119 Brody
  6. Karen T Brown
    178 Brown